Shopping Cart
- Remove All
Your shopping cart is currently empty
Terflavoxate is a novel, orally active, semisynthetic statin microtubule inhibitor commonly used in combination with capecitabine. Terflavoxate is used in cancer research.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $82 | In Stock | |
| 5 mg | $183 | In Stock | |
| 10 mg | $272 | In Stock | |
| 25 mg | $413 | In Stock | |
| 50 mg | $592 | In Stock | |
| 100 mg | $819 | In Stock | |
| 200 mg | $1,090 | In Stock |
| Description | Terflavoxate is a novel, orally active, semisynthetic statin microtubule inhibitor commonly used in combination with capecitabine. Terflavoxate is used in cancer research. |
| In vitro | Terflavoxate showed affinity for bladder (and brain) muscarinic receptors at micromolar level. Terflavoxate could inhibiting the two components of K(+)-induced contractions. Present results suggest that Ca(++)-antagonistic effects are mainly responsible for terflavoxate smooth muscle relaxant properties.[1] |
| Molecular Weight | 419.51 |
| Formula | C26H29NO4 |
| Cas No. | 86433-40-1 |
| Smiles | C(OC(CN1CCCCC1)(C)C)(=O)C2=C3C(C(=O)C(C)=C(O3)C4=CC=CC=C4)=CC=C2 |
| Color | Yellow |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| Solubility Information | DMSO: 4.19 mg/mL (10 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.